March 20th, 2024
Finding flaws in superbugs’ armor
Sponsored research agreement between Harvard and Roche resulted in the Kahne Lab’s discovery of the mechanism of action for Roche’s compound, paving the way for the development of new antibiotics.
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
March 20th, 2024
Sponsored research agreement between Harvard and Roche resulted in the Kahne Lab’s discovery of the mechanism of action for Roche’s compound, paving the way for the development of new antibiotics.
February 27th, 2024
In race against extinction, new agreement supports Harvard’s work to analyze and digitize its medicinal plant collections
February 13th, 2024
Researchers at the Andrew G Myers Research Group at the Harvard University Department of Chemistry and Chemical Biology are engineering synthetic antibiotics that directly target bacteria which cause lower respiratory tract and skin and soft tissue infections.
January 10th, 2024
A look back at moments in 2023 where researchers and industry leaders came together to connect and learn; strategic collaborations, research agreements and accelerator funding were announced; and translational research made it out of the labs for societal impact.
October 12th, 2023
Harvard University joins Mass General Brigham, Yale University, and Beth Israel Deaconess Medical Center as the initial four academic institutions to participate in LAB eN².